Center-Authored Papers

Filters: Author is Cella, David  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2010
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
2011
Cella D, Rosenbloom SK, Beaumont JL, Yount SE, Paul D, Hampton D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn JH.  2011.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(3):268-78. Abstract
Jensen SE, Rosenbloom SK, Beaumont JL, Abernethy A, Jacobsen PB, Syrjala KL, Cella D.  2011.  A new index of priority symptoms in advanced ovarian cancer.. Gynecologic oncology. 120(2):214-9. Abstract
2012
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D et al..  2012.  Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1371-7. Abstract
2013
Hlubocky FJ, Webster K, Beaumont J, Cashy J, Paul D, Abernethy A, Syrjala KL, Von Roenn J, Cella D.  2013.  A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.. Leukemia & lymphoma. 54(9):1942-6. Abstract
Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB et al..  2013.  Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.. Urologic oncology. Abstract
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD et al..  2013.  ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
Pearman TP, Beaumont JL, Paul D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn J, Cella D.  2013.  Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).. Journal of pain and symptom management. 46(1):113-20. Abstract
2014
Lai J-S, Jensen SE, Beaumont JL, Abernethy AP, Jacobsen PB, Syrjala K, Raizer JJ, Cella D.  2014.  Development of a symptom index for patients with primary brain tumors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(1):62-9. Abstract
Activities of Daily Living
Jensen SE, Rosenbloom SK, Beaumont JL, Abernethy A, Jacobsen PB, Syrjala KL, Cella D.  2011.  A new index of priority symptoms in advanced ovarian cancer.. Gynecologic oncology. 120(2):214-9. Abstract
April 2012
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D et al..  2012.  Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1371-7. Abstract
April 2013
Victorson DE, Brucker PS, Bode RK, Eton DT, Talcott JA, Clark JA, Knight SJ, Litwin MS, Moinpour CM, Reeve BB et al..  2013.  Ensuring comprehensive assessment of urinary problems in prostate cancer through patient-physician concordance.. Urologic oncology. Abstract
August 2013
Pearman TP, Beaumont JL, Paul D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn J, Cella D.  2013.  Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).. Journal of pain and symptom management. 46(1):113-20. Abstract
Center-Authored Paper
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD et al..  2013.  ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. Abstract
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
Clinical Research Division
Pearman TP, Beaumont JL, Paul D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn J, Cella D.  2013.  Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).. Journal of pain and symptom management. 46(1):113-20. Abstract
Cella D, Rosenbloom SK, Beaumont JL, Yount SE, Paul D, Hampton D, Abernethy AP, Jacobsen PB, Syrjala KL, Von Roenn JH.  2011.  Development and validation of 11 symptom indexes to evaluate response to chemotherapy for advanced cancer.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(3):268-78. Abstract
Lai J-S, Jensen SE, Beaumont JL, Abernethy AP, Jacobsen PB, Syrjala K, Raizer JJ, Cella D.  2014.  Development of a symptom index for patients with primary brain tumors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(1):62-9. Abstract
Hlubocky FJ, Webster K, Beaumont J, Cashy J, Paul D, Abernethy A, Syrjala KL, Von Roenn J, Cella D.  2013.  A preliminary study of a health related quality of life assessment of priority symptoms in advanced lymphoma: the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy - Lymphoma Symptom Index.. Leukemia & lymphoma. 54(9):1942-6. Abstract
Jensen SE, Rosenbloom SK, Beaumont JL, Abernethy A, Jacobsen PB, Syrjala KL, Cella D.  2011.  A new index of priority symptoms in advanced ovarian cancer.. Gynecologic oncology. 120(2):214-9. Abstract
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D et al..  2012.  Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(12):1371-7. Abstract
Counseling
Berger AM, Abernethy AP, Atkinson A, Barsevick AM, Breitbart WS, Cella D, Cimprich B, Cleeland C, Eisenberger MA, Escalante CP et al..  2010.  Cancer-related fatigue.. Journal of the National Comprehensive Cancer Network : JNCCN. 8(8):904-31.
Data Collection
Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, Forrest CB, Patrick DL, Fredericksen R, Shulman LM et al..  2015.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.. Medical care. 53(2):153-9. Abstract
Delivery of Health Care, Integrated
Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, Forrest CB, Patrick DL, Fredericksen R, Shulman LM et al..  2015.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.. Medical care. 53(2):153-9. Abstract
Electronic Health Records
Jensen RE, Rothrock NE, DeWitt EM, Spiegel B, Tucker CA, Crane HM, Forrest CB, Patrick DL, Fredericksen R, Shulman LM et al..  2015.  The role of technical advances in the adoption and integration of patient-reported outcomes in clinical care.. Medical care. 53(2):153-9. Abstract